Form 4/A for RMD ResMed|
Accepted 2021-11-18 00:00:00 ET · period of report 2021-11-16 · accession 0001127602-21-029616 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MA | 2021-11-18 | 2021-11-16+ | RMD | Leong Justin | Pres, Asia Latin America | A - Grant | $238.22 | +9,800 | 49.7K | +25% | +$2.33M |
| A | 2021-11-18 | 2021-11-16 | RMD | Leong Justin | Pres, Asia Latin America | F - Tax | $254.81 | -765 | 49.1K | -2% | -$194.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ReMed Common Stock | 2021-11-16 | A | A | 9,162 | $254.81 | 49,857 | D | — | — | |
| 2 | Common | ReMed Common Stock | 2021-11-18 | A | A | 638 | $0.00 | 49,730 | D | — | — | |
| 3 | Common | ReMed Common Stock | 2021-11-16 | F | D | 765 | $254.81 | 49,092 | D | — | — |